Clinical Trials Browser

Phase 4 × Drug Therapy × Clear all

NCT06931808 2025-04-17

Intestinal Microbiota Transplantation, Radiochemotherapy and Sintilimab in Localized Advanced Colon Cancer

Phase 4 Enrolling by invitation

Gastrointestinal

Localized Advanced Rectal Adenocarcinoma

NCT06893354 2025-03-25

Explore the Mechanisms Underlying Disease Resistance and Potential Primary Resistance Mechanism of Induction Therapy Lorlatinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harboring ALK Positive Mutation Revealed by Single-cell RNA Sequencing and Spatial Transcriptomics

Phase 4 Not yet recruiting

NSCLC

NCT03355157 2024-10-01

PADMA

Phase 4 Completed

Breast Neoplasms, Patient Acceptance of Health Care

NCT03691441 2023-05-17

Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal Cancer

Phase 4 Unknown

Oropharyngeal Neoplasms

NCT05840068 2023-05-03

IGF Level in Breast Cancer Patients Treated With Metformin

Phase 4 Completed

Breast Neoplasms

NCT05036005 2023-04-18

NeoON

Phase 4 Unknown

Breast Neoplasms

NCT05429515 2022-06-23

Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury

Phase 4 Not yet recruiting

GenitourinaryPlasma cell

Multiple Myeloma, Acute Kidney Injury

NCT05098990 2021-10-29

Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03986528 2021-02-23

Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 4 Unknown

NSCLC

NCT00380874 2021-02-11

Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer

Phase 4 Terminated

64 enrolled 10 charts

Pain

NCT04134247 2019-10-22

Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL

Phase 4 Unknown

Lymphoma, Non-Hodgkin

NCT03799692 2019-01-10

Albumin-Bound Paclitaxel Combined With Carboplatin as Neoadjuvant Chemotherapy in Luminal B/HER-2 Negative Breast Cancer

Phase 4 Unknown

HER-2 Negative Breast Cancer

NCT03401827 2018-02-12

The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer

Phase 4 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT00510627 2017-03-03

Prometheus

Phase 4 Withdrawn

Gastrointestinal

Liver Neoplasms, Colorectal Neoplasms

NCT01665417 2017-02-08

Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma

Phase 4 Unknown

Adenocarcinoma

NCT02782845 2016-11-21

An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL)

Phase 4 Completed

Lymphoma, Non-Hodgkin

NCT02860429 2016-08-09

Clinical Trial of Cinobufacini Injection Combined With Oxaliplatin Regimen on Gastrointestine Carcinoma

Phase 4 Unknown

Gastrointestinal

Gastrointestinal Neoplasms

NCT02000531 2016-01-13

Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population

Phase 4 Completed

45 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT01501136 2015-07-17

CTTNKTL-I/II

Phase 4 Unknown

Lymphoma, Extranodal NK-T-Cell

NCT02103257 2015-04-29

Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma

Phase 4 Unknown

Adenocarcinoma

NCT02283424 2014-11-05

Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation

Phase 4 Unknown

Neoplasms, Second Primary

NCT00664911 2013-10-16

OLD

Phase 4 Completed

Other solid neoplasm

Solid Tumor Regardless of Localization and Stage

NCT00894153 2012-04-09

p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage

Phase 4 Unknown

Neoplasms

NCT00902083 2012-04-09

rAd-p53

Phase 4 Unknown

Neoplasms

NCT00911092 2012-01-02

COL06-13

Phase 4 Completed

Gastrointestinal

Esophageal Neoplasms